Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk Loci.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 3578142)

Published in Ann Hum Genet on January 30, 2013

Authors

Patrick Holton1, Mina Ryten, Michael Nalls, Daniah Trabzuni, Michael E Weale, Dena Hernandez, Helen Crehan, J Raphael Gibbs, Richard Mayeux, Jonathan L Haines, Lindsay A Farrer, Margaret A Pericak-Vance, Gerard D Schellenberg, Alzheimer's Disease Genetics Consortium, Manuel Ramirez-Restrepo, Anzhelika Engel, Amanda J Myers, Jason J Corneveaux, Matthew J Huentelman, Allissa Dillman, Mark R Cookson, Eric M Reiman, Andrew Singleton, John Hardy, Rita Guerreiro

Author Affiliations

1: Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.

Articles citing this

Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells. Cell Stem Cell (2015) 1.61

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun (2017) 1.42

Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers. Brain Imaging Behav (2014) 1.23

Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. Neuropathology (2015) 1.21

Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways. Curr Genet Med Rep (2014) 1.18

The genetics of Alzheimer's disease. Clin Interv Aging (2014) 1.01

Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer's disease. Front Mol Neurosci (2015) 0.94

Multilocus genetic profiling to empower drug trials and predict brain atrophy. Neuroimage Clin (2013) 0.89

Alzheimer's and ABC transporters--new opportunities for diagnostics and treatment. Neurobiol Dis (2014) 0.85

Transcriptome analysis of distinct mouse strains reveals kinesin light chain-1 splicing as an amyloid-β accumulation modifier. Proc Natl Acad Sci U S A (2014) 0.85

Late-onset Alzheimer disease risk variants mark brain regulatory loci. Neurol Genet (2015) 0.83

Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis. PLoS One (2015) 0.81

Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One (2016) 0.79

Localization of mutant ubiquitin in the brain of a transgenic mouse line with proteasomal inhibition and its validation at specific sites in Alzheimer's disease. Front Neuroanat (2015) 0.79

Genes associated with Alzheimer's disease: an overview and current status. Clin Interv Aging (2016) 0.76

Family-based genome scan for age at onset of late-onset Alzheimer's disease in whole exome sequencing data. Genes Brain Behav (2015) 0.76

Predominant expression of Alzheimer's disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts. Mol Neurodegener (2016) 0.76

African American exome sequencing identifies potential risk variants at Alzheimer disease loci. Neurol Genet (2017) 0.75

Detection of membrane-bound and soluble antigens by magnetic levitation. Lab Chip (2017) 0.75

Articles cited by this

Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88

Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A (2009) 54.68

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet (2008) 30.20

Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet (2009) 16.53

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86

Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature (2007) 14.43

A survey of genetic human cortical gene expression. Nat Genet (2007) 12.04

Genomewide association studies and assessment of the risk of disease. N Engl J Med (2010) 11.51

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet (2010) 9.90

Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23

Genomewide association studies and human disease. N Engl J Med (2009) 9.05

Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet (2010) 8.74

A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet (2006) 6.98

Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet (2005) 4.80

Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A (2007) 4.71

The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007. Cell Tissue Bank (2008) 4.13

Progress and promise of genome-wide association studies for human complex trait genetics. Genetics (2010) 3.81

Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage (2008) 3.40

Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet (2009) 3.35

Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies. J Neurochem (2011) 2.82

Distinct DNA methylation changes highly correlated with chronological age in the human brain. Hum Mol Genet (2011) 2.62

Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease. Am J Hum Genet (2009) 2.56

Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet (2010) 2.51

Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Mol Biol Cell (1999) 2.49

The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc Natl Acad Sci U S A (1996) 2.49

Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice. Neuron (2002) 2.21

Plasma clusterin and the risk of Alzheimer disease. JAMA (2011) 2.19

An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet (2007) 2.14

Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro. J Biol Chem (2005) 2.03

CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol (2011) 2.02

Spatial segregation of gamma-secretase and substrates in distinct membrane domains. J Biol Chem (2005) 1.98

Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J Exp Med (1988) 1.92

Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nat Med (2011) 1.87

Evidence for CALM in directing VAMP2 trafficking. Traffic (2007) 1.84

Identification of the Alzheimer beta/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells. J Biol Chem (1993) 1.81

Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J Biol Chem (1996) 1.79

Common Alzheimer's disease risk variant within the CLU gene affects white matter microstructure in young adults. J Neurosci (2011) 1.74

Apolipoprotein J: structure and tissue distribution. Biochemistry (1990) 1.73

The amphiphysin family of proteins and their role in endocytosis at the synapse. Trends Neurosci (1998) 1.72

Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry (2011) 1.59

AMPH-1/Amphiphysin/Bin1 functions with RME-1/Ehd1 in endocytic recycling. Nat Cell Biol (2009) 1.54

Role of ATP-binding cassette transporters in brain lipid transport and neurological disease. J Neurochem (2007) 1.51

Tissue and organ donation for research in forensic pathology: the MRC Sudden Death Brain and Tissue Bank. J Pathol (2007) 1.51

Abca7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels. J Biol Chem (2004) 1.41

Structural organization of the human MS4A gene cluster on Chromosome 11q12. Immunogenetics (2001) 1.38

ATP-binding cassette, subfamily G (ABCG family). Pflugers Arch (2006) 1.37

Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease. PLoS One (2011) 1.32

Identification of a CD20-, FcepsilonRIbeta-, and HTm4-related gene family: sixteen new MS4A family members expressed in human and mouse. Genomics (2001) 1.25

Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier. Life Sci (1996) 1.24

Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons. Neuroscience (2007) 1.24

Synaptic distribution of the endocytic accessory proteins AP180 and CALM. J Comp Neurol (2005) 1.21

Purification and characterization of brain clusterin. Biochem Biophys Res Commun (1994) 1.21

ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro. J Neurochem (2008) 1.20

Genetic variability in CLU and its association with Alzheimer's disease. PLoS One (2010) 1.16

ABC transporters in cellular lipid trafficking. Curr Opin Lipidol (2000) 1.12

Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk. Mol Neurodegener (2012) 1.08

Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism. Proc Natl Acad Sci U S A (1987) 1.08

Phylogenetic analysis of the MS4A and TMEM176 gene families. PLoS One (2010) 1.06

Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways. Int J Alzheimers Dis (2011) 0.97

Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer's disease. J Alzheimers Dis (2012) 0.94

Alzheimer's risk variants in the clusterin gene are associated with alternative splicing. Transl Psychiatry (2011) 0.94

Lipid rafts play an important role in A beta biogenesis by regulating the beta-secretase pathway. J Mol Neurosci (2002) 0.93

Alzheimer's disease genetics: lessons to improve disease modelling. Biochem Soc Trans (2011) 0.91

ABC transporters and cholesterol metabolism. Front Biosci (2001) 0.83

Structural and functional correlation of the human complement receptor type 1. J Invest Dermatol (1990) 0.76

Articles by these authors

Finding the missing heritability of complex diseases. Nature (2009) 67.95

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron (2011) 18.73

Complement factor H variant increases the risk of age-related macular degeneration. Science (2005) 17.95

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Complement factor H polymorphism and age-related macular degeneration. Science (2005) 17.79

Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med (2007) 17.06

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15

Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66

Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med (2012) 14.14

Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05

Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature (2012) 13.71

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23

Genotype, haplotype and copy-number variation in worldwide human populations. Nature (2008) 12.40

A survey of genetic human cortical gene expression. Nat Genet (2007) 12.04

PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol (2010) 11.85

TREM2 variants in Alzheimer's disease. N Engl J Med (2012) 11.35

Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07

Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med (2013) 9.87

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet (2007) 9.80

Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52

Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature (2009) 9.47

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet (2011) 9.10

Genomewide association studies and human disease. N Engl J Med (2009) 9.05

Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet (2010) 8.74

A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet (2010) 8.48

Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet (2009) 8.44

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02

Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron (2010) 7.87

Identification of genetic variants using bar-coded multiplexed sequencing. Nat Methods (2008) 7.50

Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet (2004) 7.45

Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature (2009) 7.39

Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol (2006) 7.32

A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry (2007) 7.23

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet (2009) 7.16

A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science (2005) 7.03

GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron (2007) 6.88

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66

Parkinson's disease. Lancet (2009) 6.60

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci U S A (2003) 6.46

Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Am J Hum Genet (2010) 6.44

Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med (2009) 6.43

Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis (2006) 5.96

Toxic proteins in neurodegenerative disease. Science (2002) 5.82

A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet (2005) 5.81

Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol (2002) 5.69

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52

Genome-wide SNP assay reveals structural genomic variation, extended homozygosity and cell-line induced alterations in normal individuals. Hum Mol Genet (2006) 5.50